Necsa takes next step to new nuclear research reactor
Necsa issues request for information for a multipurpose reactor to replace the 56-year old Safari-1
07 February 2022 - 15:39
by Staff Writer
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
SA's nuclear reactor at Pelindaba, near Pretoria. Picture: Necsa
The SA Nuclear Energy Corporation (Necsa) on Sunday released a request for information for a multipurpose reactor (MPR) to replace its nuclear research reactor Safari-1, which is 56 years old and under care and age management.
Necsa will not award any contract as a result of the request for information and the process is intended only for information gathering.
Necsa group CEO Loyiso Tyabashe said the MPR will continue Safari-1’s legacy of “producing medical radioisotopes, which are used to treat thousands of patients diagnosed with cancer all over the world”. NTP Radioisotopes, a wholly owned Necsa subsidiary, is among the top four producers of radioisotopes in the world, he said.
Necsa chair David Nicholls said the MPR will create about750 full-time jobs and an additional 3,800 indirect jobs “for its operation and fulfilment of its research mandate during its operational lifetime”.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Necsa takes next step to new nuclear research reactor
Necsa issues request for information for a multipurpose reactor to replace the 56-year old Safari-1
The SA Nuclear Energy Corporation (Necsa) on Sunday released a request for information for a multipurpose reactor (MPR) to replace its nuclear research reactor Safari-1, which is 56 years old and under care and age management.
Necsa will not award any contract as a result of the request for information and the process is intended only for information gathering.
Necsa group CEO Loyiso Tyabashe said the MPR will continue Safari-1’s legacy of “producing medical radioisotopes, which are used to treat thousands of patients diagnosed with cancer all over the world”. NTP Radioisotopes, a wholly owned Necsa subsidiary, is among the top four producers of radioisotopes in the world, he said.
Necsa chair David Nicholls said the MPR will create about750 full-time jobs and an additional 3,800 indirect jobs “for its operation and fulfilment of its research mandate during its operational lifetime”.
‘Activist’ nuclear board official sues Mantashe over suspension
PETER ATTARD MONTALTO: Let’s deal in real evidence and hard facts
GRAY MAGUIRE: Becker’s removal another nail in the coffin of nuclear transparency
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Related Articles
BJORN LOMBORG: Misguided climate panic ignores human ingenuity
Lights to remain on despite rain and Koeberg shutdown
WATCH: Eskom inertia remains biggest economic risk
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.